Exeter Financial’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $906K | Sell |
9,886
-414
| -4% | -$36.2K | 0.35% | 63 |
|
|
2026
Q1 | $878K | Sell |
10,300
-1,054
| -9% | -$93.9K | 0.36% | 62 |
|
|
2025
Q4 | $897K | Sell |
11,354
-2,287
| -17% | -$179K | 0.38% | 63 |
|
|
2025
Q3 | $1.09M | Buy |
13,641
+8
| +0.1% | +$682 | 0.47% | 59 |
|
|
2025
Q2 | $1.24M | Sell |
13,633
-615
| -4% | -$56.1K | 0.55% | 58 |
|
|
2025
Q1 | $1.34M | Buy |
14,248
+395
| +3% | +$35.4K | 0.6% | 52 |
|
|
2024
Q4 | $1.26M | Buy |
13,853
+346
| +3% | +$33K | 0.58% | 54 |
|
|
2024
Q3 | $1.4M | Buy |
13,507
+147
| +1% | +$15K | 0.62% | 51 |
|
|
2024
Q2 | $1.3M | Buy |
13,360
+130
| +1% | +$12K | 0.62% | 51 |
|
|
2024
Q1 | $1.16M | Buy |
13,230
+1,215
| +10% | +$103K | 0.53% | 56 |
|
|
2023
Q4 | $971K | Buy |
12,015
+172
| +1% | +$12.9K | 0.47% | 58 |
|
|
2023
Q3 | $842K | Buy |
11,843
+424
| +4% | +$31.7K | 0.44% | 62 |
|
|
2023
Q2 | $861K | Sell |
11,419
-4,370
| -28% | -$338K | 0.44% | 62 |
|
|
2023
Q1 | $1.19M | Sell |
15,789
-384
| -2% | -$28.6K | 0.59% | 57 |
|
|
2022
Q4 | $1.27M | Sell |
16,173
-1,846
| -10% | -$138K | 0.66% | 56 |
|
|
2022
Q3 | $1.27M | Sell |
18,019
-36
| -0.2% | -$2.82K | 0.74% | 50 |
|
|
2022
Q2 | $1.45M | Buy |
18,055
+197
| +1% | +$15.4K | 0.81% | 48 |
|
|
2022
Q1 | $1.35M | Buy |
17,858
+1,059
| +6% | +$83.9K | 0.73% | 48 |
|
|
2021
Q4 | $1.41M | Buy |
16,799
+425
| +3% | +$33.2K | 0.77% | 50 |
|
|
2021
Q3 | $1.24M | Buy |
16,374
+465
| +3% | +$36.9K | 0.74% | 49 |
|
|
2021
Q2 | $1.3M | Buy |
15,909
+1,084
| +7% | +$88.6K | 0.75% | 48 |
|
|
2021
Q1 | $1.17M | Buy |
14,825
+938
| +7% | +$73.5K | 0.74% | 51 |
|
|
2020
Q4 | $1.19M | Buy |
13,887
+472
| +4% | +$39K | 0.82% | 45 |
|
|
2020
Q3 | $1.03M | Buy |
13,415
+69
| +0.5% | +$5.26K | 0.81% | 48 |
|
|
2020
Q2 | $978K | Sell |
13,346
-32
| -0.2% | -$2.27K | 0.81% | 46 |
|
|
2020
Q1 | $888K | Buy |
13,378
+1,018
| +8% | +$71.8K | 0.83% | 46 |
|
|
2019
Q4 | $851K | Sell |
12,360
-106
| -0.9% | -$7.23K | 0.66% | 51 |
|
|
2019
Q3 | $916K | Sell |
12,466
-386
| -3% | -$28K | 0.73% | 51 |
|
|
2019
Q2 | $921K | Buy |
12,852
+60
| +0.5% | +$4.26K | 0.77% | 51 |
|
|
2019
Q1 | $877K | Sell |
12,792
-39
| -0.3% | -$2.52K | 0.76% | 51 |
|
|
2018
Q4 | $764K | Sell |
12,831
-3,017
| -19% | -$189K | 0.72% | 52 |
|
|
2018
Q3 | $1.06M | Buy |
15,848
+30
| +0.2% | +$2K | 0.87% | 48 |
|
|
2018
Q2 | $1.02M | Buy |
15,818
+668
| +4% | +$43.7K | 0.9% | 46 |
|
|
2018
Q1 | $1.09M | Buy |
15,150
+1,441
| +11% | +$104K | 0.93% | 44 |
|
|
2017
Q4 | $1.03M | Buy |
+13,709
| New | +$1M | 0.9% | 42 |
|
Other funds holding CL
SP
PAM
CIM
AAMU
JIC
WG
Exeter Financial's CL Position: Q2 2026 in Review
Exeter Financial reduced its Colgate-Palmolive (CL) stake by 4% in Q2 2026, selling an estimated $36.2K and leaving 9,886 shares worth $906K. The position accounts for 0.35% of the portfolio, ranked #63.
Exeter Financial first reported a position in CL in Q4 2017 and has held it in 35 quarters since. The position peaked at $1.45M in Q2 2022. 606 funds tracked by Wall St. Rank hold CL as of Q2 2026.
- Exeter Financial held 9,886 shares of Colgate-Palmolive worth $906K as of Q2 2026.
- Exeter Financial sold 414 Colgate-Palmolive shares in Q2 2026, an estimated $36.2K.
- Colgate-Palmolive made up 0.35% of Exeter Financial's portfolio in Q2 2026, its #63 holding.
- Exeter Financial first reported a position in Colgate-Palmolive in Q4 2017 and has held it in 35 quarters since.
- Exeter Financial's Colgate-Palmolive position peaked at $1.45M in Q2 2022.
- 606 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.
Based on Exeter Financial's 13F filing for Q2 2026, filed 16 Jul 2026.